Dexmedetomidine as an adjuvant analgesic for intractable cancer pain

Seth B. Roberts, Colin P. Wozencraft, Patrick J. Coyne, Thomas J. Smith

Research output: Contribution to journalArticlepeer-review


Dexmedetomidine (Precedex®) is an alpha-2 adrenergic agonist that can produce sedation and analgesia without causing respiratory depression. Its use has been described in patients undergoing mechanical ventilation, sedation for surgical and nonsurgical procedures, and prevention of withdrawal. We describe its use as an adjuvant analgesic in a patient with cancer pain refractory to multiple treatment modalities.

Original languageEnglish (US)
Pages (from-to)371-373
Number of pages3
JournalJournal of palliative medicine
Issue number3
StatePublished - Mar 1 2011
Externally publishedYes

ASJC Scopus subject areas

  • Nursing(all)
  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Dexmedetomidine as an adjuvant analgesic for intractable cancer pain'. Together they form a unique fingerprint.

Cite this